TARGETING CTPS1 AND NUCLEOTIDE BIOSYNTHESIS PATHWAYS AS A NOVEL THERAPEUTIC APPROACH IN MYC-AMPLIFIED MEDULLOBLASTOMA

被引：0
|
作者：
Hathaway, Matthew [1 ]
Jagana, Hawa [1 ]
Terrones, Isabella [1 ]
Miyaki, Aya [1 ]
Hemenway, John [1 ]
Meechan, Michael [1 ]
Gadek, Kate [1 ]
Slusher, Barbara [2 ]
Evans II, Myron [1 ,3 ]
机构：
[1] Seattle Childrens Res Inst, Ben Towne Ctr, Seattle, WA USA
[2] Johns Hopkins Med, Baltimore, MD USA
[3] Univ Washington, Dept Pediat, Seattle, WA USA
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae064.549
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MDB-101
引用
收藏
页数：1
相关论文
共 50 条
  • [1] TARGETING CTPS1 AND NUCLEOTIDE BIOSYNTHESIS PATHWAYS AS A NOVEL THERAPEUTIC APPROACH IN MYC-AMPLIFIED MEDULLOBLASTOMA
    Hathaway, Matthew
    Jagana, Hawa
    Meechan, Michael
    Rajendran, Ashmitha
    Slusher, Barbara
    Evans, Myron, II
    NEURO-ONCOLOGY, 2023, 25
  • [2] Targeting CTPS1 and nucleotide biosynthesis pathways as a novel therapeutic approach in MYC-amplified medulloblastoma
    Hathaway, Matthew
    Jagana, Hawa
    Meechan, Michael
    Hemenway, John
    Gadek, Kate E.
    Miyaki, Aya
    Terrones, Isabella
    Slusher, Barbara
    Pattwell, Siobhan
    Vitanza, Nicholas
    Evans, Myron K.
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Targeting protein synthesis pathways in MYC-amplified medulloblastoma
    Kumar, Devendra
    Kanchan, Ranjana
    Chaturvedi, Nagendra K.
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [4] SCD1 is a potent therapeutic target in MYC-amplified group 3 medulloblastoma
    Custers, Stefan
    Escudero, Laura
    Suk, Yujin
    McKenna, Dillon
    Gwynne, William
    Chaudhry, Iqra
    Chan, Jeremy
    Quaile, Andrew
    Moffat, Jason
    Venugopal, Chitra
    Montenegro-Burke, Rafael
    Singh, Sheila
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [5] SERINE/GLYCINE METABOLISM REPRESENTS A NOVEL TARGETABLE THERAPEUTIC VULNERABILITY IN MYC-AMPLIFIED MEDULLOBLASTOMA
    Adiamah, Magretta
    Poole, Bethany
    Lindsey, Janet C.
    Swartz, Shanel
    Morcavallo, Alaide
    Gosling, Samantha Jepson
    Singh, Mankaran
    Blair, Helen J.
    Kohe, Sarah
    Zhang, Tong
    Maddocks, Oliver
    Peet, Andrew
    Chesler, Louis
    Hickson, Ian
    Maxwell, Ross
    Hill, Rebecca M.
    Clifford, Steven C.
    NEURO-ONCOLOGY, 2024, 26
  • [6] PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma
    Kumar, Devendra
    Jain, Stuti
    Coulter, Don W.
    Joshi, Shantaram S.
    Chaturvedi, Nagendra K.
    CANCERS, 2023, 15 (24)
  • [7] Targeting Y box binding protein 1 (YBX1) in MYC-amplified medulloblastoma
    Carney, Stephen
    Hemenway, John
    Rajendran, Ashmitha
    Hathaway, Matt
    Nealy, Eric
    Bonatto, Christian
    Tailor, Dhanir
    Malhotra, Sanjay
    Evans, Myron
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Effective Inhibition of MYC-Amplified Group 3 Medulloblastoma Through Targeting EIF4A1
    Zhao, Yang
    Li, Tiantian
    Tian, Shuaiwei
    Meng, Wei
    Sui, Yi
    Yang, Jian
    Wang, Baocheng
    Liang, Zhuangzhuang
    Zhao, Heng
    Han, Yipeng
    Tang, Yujie
    Zhang, Lei
    Ma, Jie
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 12473 - 12485
  • [9] CTPS1 is a novel therapeutic target in cutaneous T cell lymphoma
    Beer, P.
    Ahearne, M.
    Collins, G.
    El-Sharkawi, D.
    Fox, C.
    Lewis, D.
    Linton, K.
    Patel, M.
    Tees, M.
    Schwartz, B.
    Higgins, M.
    Noel, R.
    Michot, J. -M.
    Ribrag, V.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S20 - S21
  • [10] MYC-DRIVEN UPREGULATION OF THE DE NOVO SERINE AND GLYCINE PATHWAY IS A NOVEL THERAPEUTIC TARGET FOR GROUP 3 MYC-AMPLIFIED MEDULLOBLASTOMA
    Adiamah, Magretta
    Lindsey, Janet C.
    Burte, Florence
    Kohe, Sarah
    Morcavallo, Alaide
    Blair, Helen
    Hill, Rebecca M.
    Singh, Mankaran
    Crosier, Stephen
    Zhang, Tong
    Maddocks, Oliver
    Peet, Andrew
    Chesler, Louis
    Hickson, Ian
    Maxwell, Ross
    Clifford, Steven C.
    NEURO-ONCOLOGY, 2022, 24 : 125 - 125
12345